AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Eli Lilly and Comp. (LLY) stock Forecast for 2023, 2024, 2025, 2026
The forecast has been updated: September 29, 2023 8:40
Eli Lilly and Comp. stock price online today
Analyst Target Price
569.28Dividend Date
08.09.2023Ex Dividend Date
14.08.2023Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Eli Lilly and Comp. stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2023, 2024, 2025?
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $569.28 target price for Eli Lilly and Comp. stock stock.
Today 200 Day Moving Average is the resistance level (417.83 $).
50 Day Moving Average is the resistance level (526.51 $).
Eli Lilly and Comp. stock monthly Forecast
| Date | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| 01 Oct 23 | 244.38 | 240.93 | 248.48 | 3.13 % |
| 02 Oct 23 | 243.13 | 238.03 | 245.68 | 3.22 % |
| 03 Oct 23 | 237.66 | 235.52 | 241.87 | 2.69 % |
| 04 Oct 23 | 241.15 | 238.26 | 244.12 | 2.46 % |
| 05 Oct 23 | 244.48 | 239.79 | 247.49 | 3.21 % |
| 06 Oct 23 | 247.20 | 241.41 | 250.24 | 3.66 % |
| 07 Oct 23 | 247.86 | 245.78 | 253.66 | 3.21 % |
| 08 Oct 23 | 247.19 | 245.49 | 250.31 | 1.96 % |
| 09 Oct 23 | 251.64 | 245.68 | 256.02 | 4.21 % |
| 10 Oct 23 | 249.53 | 247.21 | 251.48 | 1.73 % |
| 11 Oct 23 | 253.27 | 251.68 | 255.93 | 1.69 % |
| 12 Oct 23 | 250.69 | 247.83 | 253.02 | 2.09 % |
| 13 Oct 23 | 249.86 | 245.81 | 252.19 | 2.59 % |
| 14 Oct 23 | 254.28 | 250.93 | 257.79 | 2.74 % |
| 15 Oct 23 | 253.67 | 249.95 | 255.42 | 2.19 % |
| 16 Oct 23 | 253.67 | 247.89 | 256.26 | 3.38 % |
| 17 Oct 23 | 252.76 | 248.74 | 257.16 | 3.38 % |
| 18 Oct 23 | 254.35 | 248.33 | 259.16 | 4.36 % |
| 19 Oct 23 | 254.81 | 250.45 | 259.70 | 3.69 % |
| 20 Oct 23 | 251.68 | 246.85 | 256.13 | 3.76 % |
| 21 Oct 23 | 252.28 | 248.19 | 255.38 | 2.90 % |
| 22 Oct 23 | 251.83 | 248.96 | 254.02 | 2.03 % |
| 23 Oct 23 | 256.28 | 251.13 | 260.67 | 3.80 % |
| 24 Oct 23 | 255.67 | 249.99 | 259.43 | 3.77 % |
| 25 Oct 23 | 261.27 | 256.72 | 267.23 | 4.09 % |
| 26 Oct 23 | 258.76 | 255.03 | 264.43 | 3.68 % |
| 27 Oct 23 | 262.64 | 258.94 | 267.21 | 3.19 % |
| 28 Oct 23 | 259.57 | 254.12 | 261.36 | 2.85 % |
| 29 Oct 23 | 259.65 | 256.06 | 264.48 | 3.29 % |
| 30 Oct 23 | 258.95 | 252.73 | 265.16 | 4.92 % |
LLY daily forecast for this month
Estimated Average Forecasted Eli Lilly and Comp. Price: 244.38 Positive intraday dynamics of the instrument is expected with 3.039% volatility is expected.
Pessimistic forecast: 240.93
Optimistic: 248.48
Eli Lilly and Comp. stock forecast for 02.10.2023.
Estimated Average Forecasted Eli Lilly and Comp. Price: 243.13 Negative intraday dynamics of the instrument is expected with 3.117% volatility is expected.
Pessimistic forecast: 238.03
Optimistic: 245.68
Eli Lilly and Comp. stock forecast for 03.10.2023.
Estimated Average Forecasted Eli Lilly and Comp. Price: 237.66 Negative intraday dynamics of the instrument is expected with 2.624% volatility is expected.
Pessimistic forecast: 235.52
Optimistic: 241.87
Eli Lilly and Comp. stock forecast for 04.10.2023.
Estimated Average Forecasted Eli Lilly and Comp. Price: 241.15 Positive intraday dynamics of the instrument is expected with 2.400% volatility is expected.
Pessimistic forecast: 238.26
Optimistic: 244.12
Eli Lilly and Comp. stock forecast for 05.10.2023.
Estimated Average Forecasted Eli Lilly and Comp. Price: 244.48 Positive intraday dynamics of the instrument is expected with 3.112% volatility is expected.
Pessimistic forecast: 239.79
Optimistic: 247.49
LLY Forecast for 2023
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Oct | 229.04 | 217.73 | 247.21 | 11.92 % |
| Nov | 226.66 | 212.22 | 242.87 | 12.62 % |
| Dec | 235.79 | 215.87 | 243.76 | 11.44 % |
Eli Lilly and Comp. stock forecast for this year
Eli Lilly and Comp. share price average forecast for Oct 2023 is: 229.042 The dynamics are negative.
Eli Lilly and Comp. share price average forecast for Nov 2023 is: 226.66 The dynamics are negative.
Eli Lilly and Comp. share price average forecast for Dec 2023 is: 235.794 The dynamics are positive.
Eli Lilly and Comp. stock Forecast for 2024
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 242.54 | 235.29 | 250.74 | 6.16 % |
| Feb | 239.70 | 224.74 | 248.43 | 9.53 % |
| Mar | 224.43 | 210.43 | 247.19 | 14.87 % |
| Apr | 252.73 | 227.11 | 260.95 | 12.97 % |
| May | 266.53 | 249.55 | 294.25 | 15.19 % |
| Jun | 277.62 | 270.04 | 288.81 | 6.50 % |
| Jul | 271.12 | 259.84 | 282.05 | 7.87 % |
| Aug | 267.95 | 252.97 | 282.23 | 10.37 % |
| Sep | 253.32 | 246.41 | 270.12 | 8.78 % |
| Oct | 248.71 | 235.78 | 264.88 | 10.99 % |
| Nov | 259.06 | 232.79 | 284.65 | 18.22 % |
| Dec | 259.39 | 245.91 | 269.17 | 8.64 % |
Eli Lilly and Comp. stock Forecast for 2025
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 276.25 | 257.94 | 290.62 | 11.25 % |
| Feb | 310.37 | 292.22 | 324.09 | 9.84 % |
| Mar | 339.83 | 309.79 | 355.29 | 12.81 % |
| Apr | 368.98 | 349.32 | 395.85 | 11.75 % |
| May | 375.70 | 344.93 | 414.28 | 16.74 % |
| Jun | 328.32 | 295.46 | 345.82 | 14.56 % |
| Jul | 348.38 | 337.97 | 366.95 | 7.90 % |
| Aug | 342.50 | 309.55 | 357.63 | 13.45 % |
| Sep | 346.50 | 316.32 | 380.74 | 16.92 % |
| Oct | 367.67 | 355.72 | 404.48 | 12.05 % |
| Nov | 390.62 | 353.04 | 422.61 | 16.46 % |
| Dec | 433.78 | 418.55 | 477.77 | 12.39 % |
Eli Lilly and Comp. stock Forecast for 2026
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 411.22 | 388.77 | 447.04 | 13.03 % |
| Feb | 437.95 | 414.04 | 469.84 | 11.88 % |
| Mar | 404.36 | 377.55 | 440.63 | 14.32 % |
| Apr | 423.29 | 408.98 | 435.39 | 6.07 % |
| May | 476.11 | 428.45 | 488.49 | 12.29 % |
| Jun | 445.17 | 420.86 | 490.88 | 14.26 % |
| Jul | 474.68 | 454.93 | 488.87 | 6.94 % |
| Aug | 527.75 | 483.84 | 579.20 | 16.46 % |
| Sep | 544.90 | 513.02 | 568.28 | 9.72 % |
| Oct | 576.07 | 548.36 | 597.04 | 8.15 % |
| Nov | 583.56 | 535.76 | 632.11 | 15.24 % |
| Dec | 556.25 | 536.72 | 594.57 | 9.73 % |
Eli Lilly and Comp. stock Forecast for 2027
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 559.14 | 506.08 | 609.29 | 16.94 % |
| Feb | 556.96 | 524.38 | 605.47 | 13.39 % |
| Mar | 571.44 | 552.87 | 589.27 | 6.18 % |
| Apr | 540.24 | 519.17 | 573.95 | 9.54 % |
| May | 505.83 | 491.36 | 530.16 | 7.32 % |
| Jun | 493.99 | 459.31 | 521.60 | 11.94 % |
| Jul | 523.53 | 469.76 | 545.99 | 13.96 % |
| Aug | 557.56 | 516.97 | 597.43 | 13.47 % |
| Sep | 592.35 | 561.55 | 611.60 | 8.18 % |
| Oct | 647.80 | 622.53 | 707.59 | 12.02 % |
| Nov | 678.95 | 657.77 | 707.20 | 6.99 % |
| Dec | 704.55 | 639.52 | 775.08 | 17.49 % |
Eli Lilly and Comp. overview
Eli Lilly and Comp. Address
LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, USMarket Capitalization
522 121 740 000 $EBITDA
9 765 000 000PE Ratio
76.28PEG Ratio
2.181Dividend Per Share
4.22Dividend Yield
0.0082EPS
7.21Quarterly Earnings Growth YOY
0.857Quarterly Revenue Growth YOY
0.281Trailing PE
76.28Forward PE
39.06EV To Revenue
12.18EV To EBITDA
42.0452 Week High
601.8452 Week Low
307.7450 Day Moving Average
526.51200 Day Moving Average
417.83Shares Outstanding
949295000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
 Abbott Laboratories
|
ABT | 107.28 (19.07.2023) | 0.31 % |
 AbbVie Inc.
|
ABBV | 137.68 (19.07.2023) | 0.81 % |
 Aeterna Zentaris Inc.
|
AEZS | 2.87 (14.07.2023) | -1.03 % |
 Allakos Inc.
|
ALLK | 4.65 (14.07.2023) | -2.11 % |
 Allogene Therapeutics, Inc.
|
ALLO | 4.96 (14.07.2023) | -4.89 % |
 Amgen Inc.
|
AMGN | 232.57 (18.07.2023) | 2.08 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 1.83 (14.07.2023) | -8.04 % |
 Aurora Cannabis Inc.
|
ACB | 0.534 (14.07.2023) | -5.94 % |
 Becton Dickinson and Company
|
BDX | 259.39 (14.07.2023) | -0.22 % |
 Biogen Inc.
|
BIIB | 278.4 (17.07.2023) | -0.19 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 26.24 (18.07.2023) | -0.64 % |
 BioNTech SE
|
BNTX | 109.13 (19.07.2023) | 0.91 % |
 bluebird bio, Inc.
|
BLUE | 3.03 (14.07.2023) | -8.46 % |
 Boston Scientific Corp.
|
BSX | 53.03 (14.07.2023) | 0.45 % |
 Bristol-Myers Squibb Company
|
BMY | 61.85 (17.07.2023) | -0.15 % |
 Canopy Growth Corp.
|
CGC | 0.3841 (14.07.2023) | -40.91 % |
 Castle Biosciences, Inc.
|
CSTL | 16.83 (18.07.2023) | 2.00 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
|
Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
 Emergent BioSolutions Inc.
|
EBS | 7.21 (14.07.2023) | -0.96 % |
 Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
 G1 Therapeutics, Inc.
|
GTHX | 2.41 (14.07.2023) | -0.82 % |
 Gilead Sciences, Inc.
|
GILD | 77.19 (14.07.2023) | 0.63 % |
 GlaxoSmithKline plc
|
GSK | 34.53 (14.07.2023) | -0.78 % |
 GoodRx Holdings, Inc.
|
GDRX | 7.46 (14.07.2023) | 1.77 % |
 GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 61.08 (17.07.2023) | -1.10 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 0.5392 (17.07.2023) | 2.70 % |
 Johnson & Johnson
|
JNJ | 166.11 (13.04.2023) | 1.34 % |
 Medtronic plc.
|
MDT | 86.12 (19.07.2023) | -0.55 % |
 Merck & Co., Inc.
|
MRK | 105.57 (17.07.2023) | -1.65 % |
 Moderna, Inc.
|
MRNA | 121.35 (14.07.2023) | -4.15 % |
 Novartis AG
|
NVS | 98.83 (14.07.2023) | 0.51 % |
 Novavax, Inc.
|
NVAX | 8.68 (14.07.2023) | -6.06 % |
 ObsEva SA
|
OBSV | 0.05 (14.07.2023) | 0.00 % |
 OrganiGram Holdings Inc.
|
OGI | 1.49 (17.07.2023) | -4.49 % |
 Pfizer Inc.
|
PFE | 35.86 (17.07.2023) | -1.27 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 721.61 (17.07.2023) | 0.43 % |
 Sanofi
|
SNY | 52.68 (14.07.2023) | 1.07 % |
 Schrodinger, Inc.
|
SDGR | 55.01 (18.07.2023) | 0.88 % |
 Senseonics Holdings, Inc.
|
SENS | 0.875 (14.07.2023) | -3.90 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 0.35 (14.07.2023) | -0.28 % |
 Stryker Corp.
|
SYK | 298.62 (17.07.2023) | -1.26 % |
 Sundial Growers Inc.
|
SNDL | 1.42 (17.07.2023) | 1.43 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.56 (19.07.2023) | 5.29 % |
 Thermo Fisher Scientific Inc.
|
TMO | 535.55 (19.07.2023) | 2.27 % |
 Tilray, Inc.
|
TLRY | 1.69 (17.07.2023) | 1.81 % |
 UnitedHealth Group, Inc.
|
UNH | 480.17 (14.07.2023) | 7.24 % |
 Veeva Systems Inc.
|
VEEV | 206.17 (19.07.2023) | -1.52 % |
|
Zomedica Corp.
|
ZOM | 0.2114 (14.07.2023) | -5.41 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 0.371 (19.07.2023) | 1.64 % |
Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.